Syngene International Ltd
Putting Science to Work
- Website
- syngeneintl.com · all feeds from this site
- Feed URL
https://www.syngeneintl.com/feed/
Read it in your FeedListing reader
Or add to: Feedly Inoreader Raw feed
Latest posts
-
ADC Manufacturing Challenges: Where Programs Most Often Lose Momentum
Explore ADC manufacturing challenges across conjugation, analytics, scale-up, and technology transfer. See how teams can keep programs moving. The post ADC Manufacturing Challenges: Where Programs Most Often Lose Momentum appeared first on Syngene International Ltd .
-
Biomarkers in Clinical Trials: Why They Matter in First-in-Human Studies
See how biomarkers in clinical trials support target engagement, dose selection, and early development decisions. Explore Syngene’s capabilities. The post Biomarkers in Clinical Trials: Why They Matter in First-in-Human Studies appeared first on Syngene International Ltd .
-
ALCOA Principles and Data Integrity in Clinical Trials: What the BIOSECURE Act Changes
Publication: Pharma Technology Focus The post ALCOA Principles and Data Integrity in Clinical Trials: What the BIOSECURE Act Changes appeared first on Syngene International Ltd .
-
Organ-on-Chip Platform: Bringing Human Biology closer to Drug Discovery and DMPK
See how an organ-on-a-chip platform can add human-relevant insight to drug discovery, DMPK and skin permeability studies. Read more. The post Organ-on-Chip Platform: Bringing Human Biology closer to Drug Discovery and DMPK appeared first on Syngene International Ltd .
-
Sterile Fill Finish Manufacturing at Scale: How Integrated DS+DP+FF Reduces Late-Stage Surprises
Explore how integrated sterile fill-finish manufacturing reduces transfer risks and supports clinical-to-commercial scale-up. Read the article. The post Sterile Fill Finish Manufacturing at Scale: How Integrated DS+DP+FF Reduces Late-Stage Surprises appeared first on Syngene…
-
Why ADC Linker Payload Design Is the Real Differentiator in ADC Success
See how ADC linker payload design, DAR, linker choice, bystander killing, and bioconjugation shape efficacy and safety. Read the article. The post Why ADC Linker Payload Design Is the Real Differentiator in ADC Success appeared first on Syngene International Ltd .
-
Why CDMO Outsourcing is Moving Earlier in Biologics Development
Learn why CDMO outsourcing is moving earlier in biologics development and how early CMC strategy can reduce late-stage risk. Read more. The post Why CDMO Outsourcing is Moving Earlier in Biologics Development appeared first on Syngene International Ltd .
-
A Complete Nonclinical GLP Tox Study Package for a Successful IND Submission in Six Months
See how Syngene delivered a complete GLP tox study package for ART26.12 and supported IND submission in six months. Read the case study. The post A Complete Nonclinical GLP Tox Study Package for a Successful IND Submission in Six Months appeared first on Syngene International…
-
The New-Age CRDMO: Rethinking Drug Development Partnerships
Explore how the antibody drug conjugates market, AI, supply resilience and integrated CRDMOs are reshaping drug development outsourcing. Read more. The post The New-Age CRDMO: Rethinking Drug Development Partnerships appeared first on Syngene International Ltd .
-
Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates
Explore how flow chemistry supports poorly soluble pharmaceutical intermediates through better mixing, precipitation control, and crystallization. Read now. The post Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates appeared first on Syngene International…